Gary Phillips
Chairman at NANOBIOTIX
Net worth: 58 359 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Todd Brady | M | 52 |
Helio Vision, Inc.
 Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 19 years |
| Nikhilesh N. Singh | M | 65 |
OrphoMed, Inc.
 OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | - |
| Richard Douglas | M | 71 |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 8 years |
| Daniel Peisert | M | 49 | 4 years | |
| Martin Joyce | M | 70 |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 11 years |
| Bruce Greenberg | M | 56 | 5 years | |
| Nikolaos Stergiopulos | M | - |
Rheon Medical SA
 Rheon Medical SA Medical SpecialtiesHealth Technology Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland. | - |
| Nancy Miller-Rich | F | 65 |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 4 years |
| Jesse I. Treu | M | 76 |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 9 years |
| Ben Bronstein | M | 74 |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 14 years |
| Todd Smith | M | 55 | 5 years | |
| Onur Boyman | M | - |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | - |
| Anne-Marie Graffin | F | 63 | 10 years | |
| Andreas Katopodis | M | - |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | 6 years |
| James A. Gow | M | - | 4 years | |
| Laurent Lévy | M | 53 | 21 years | |
| Dean Eliott | M | - |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | 8 years |
| Enno Spillner | M | 55 | 10 years | |
| Neal Walker | M | 54 | 11 years | |
| Margaret Galluzzi | F | - | 5 years | |
| Alex Hamilton | M | - |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | 2 years |
| Brandon Owens | M | - | - | |
| Anne-Juliette Hermant | F | 51 | 5 years | |
| Stephen Machatha | M | 47 | 3 years | |
| Bart van Rhijn | M | 52 | 3 years | |
| Neil Walker | M | - |
Helio Vision, Inc.
Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | - |
| Kelly Mizer | M | - | 3 years | |
| Caitlin Pazzano | F | - | 2 years | |
| Anderson Timothy | M | - |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | - |
| Alain Herrera | M | 74 | 13 years | |
| Florian Muellershausen | M | - |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | 5 years |
| Claude Romy | M | - |
Rheon Medical SA
Rheon Medical SA Medical SpecialtiesHealth Technology Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland. | - |
| Robert W. Holthausen | M | 76 |
The Wharton School of the University of Pennsylvania
| 35 years |
| Thomas P. Gerrity | M | 82 |
The Wharton School of the University of Pennsylvania
| 34 years |
| Art Pappas | M | 76 |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | - |
| Mark I. Greene | M | 75 |
Perelman School of Medicine
| 35 years |
| Martin Murphy | M | 55 |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | 5 years |
| Ran Nussbaum | M | 51 |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | - |
| Thomas Zehnder | M | - |
Rheon Medical SA
Rheon Medical SA Medical SpecialtiesHealth Technology Rheon Medical SA develops adjustable glaucoma drainage devices. The firm manufactures eyeWatch, a drainage device for the treatment of glaucoma. It also offers control unit, an instrument that measures and adjusts the eyeWatch's functional position. The company was founded by Nikolaos Stergiopulos and is headquartered in Lausanne, Switzerland. | - |
| Pankaj Jay Pasricha | M | - |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | - |
| Michael Martin | M | 50 |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | - |
| Barbara Kahn | M | 71 |
The Wharton School of the University of Pennsylvania
| 34 years |
| Louis Kayitalire | M | 66 | 1 years | |
| Allison Jeynes-Ellis | M | 58 |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | - |
| Patrick Tricoli | M | - | 10 years | |
| Frank Steinberg | M | - |
OrphoMed, Inc.
OrphoMed, Inc. Pharmaceuticals: MajorHealth Technology OrphoMed, Inc. develops and manufactures pharmaceutical products. The company was founded Pankaj Jay Pasricha and Frank Steinberg and is headquartered in Mill Valley, CA. | - |
| Craig West | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Radie | M | 60 | 7 years | |
| Timothy Walbert | M | 57 | 6 years | |
| William H. Waltrip | M | 86 |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 17 years |
| Stephen Tulipano | M | 65 | 4 years | |
| J. Michael Judy | M | - |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 2 years |
| Michele Galen | F | 67 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | 2 years |
| Michael D. Gowen | M | 75 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | - |
| Joseph McInnis | M | 48 | 1 years | |
| Laurent Condomine | M | 79 | 10 years | |
| Farid Harianto | M | 68 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Adam Blackman | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Andrea Smiley | F | 56 | 3 years | |
| Megan Timmins | F | 51 | 4 years | |
| Lee Jeffrey Tawil | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Lawrence Berger | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Todd Holmes | M | - | 1 years | |
| Joshua Reed | M | 51 | 4 years | |
| Richard Sol Nackenson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Stephen McCluski | M | 72 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 19 years |
| Gregory Weaver | M | 68 | 6 years | |
| Patrick Enright | M | 62 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Michael Bühler | M | - |
Forum Mondial de L'Economie
 Forum Mondial de L'Economie Miscellaneous Commercial ServicesCommercial Services Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland. | 6 years |
| Jamie Kramer | F | - |
The Wharton School of the University of Pennsylvania
| 12 years |
| Andrew Pearson | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Mark Strobeck | M | 53 | 6 years | |
| Louis A. Toth | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
| Gary Rosenthal | M | - |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | - |
| Robert Schrader | M | 52 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 10 years |
| Adam Goodfriend | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Andrew Ragusa | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jenny Lefcourt | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| William Shraga | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Brett Rowland | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Gang Yu | M | 64 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Ted Joseph | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| John C. Chan | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Jorge Mora | M | 57 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Sean H. Reynolds | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Todd Briddell | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Andrew Brian Wellington | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Martin Ignacio Lorenzo | M | 59 |
The Wharton School of the University of Pennsylvania
| 2 years |
| Reynir Kjær Indahl | M | 54 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Kumar Doraiswami | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Pierre Sylvio LeComte | M | 51 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Robert Kosian | M | - |
The Wharton School of the University of Pennsylvania
| - |
| John Antonio | M | 51 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Buddy L. Arnheim | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Jeff Bell | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Brad Corrodi | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
| Steve Krognes | M | 56 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Ashish Kishore | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
| Carlos M. Lopez-Oña | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
| Leigh Wasson | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 76 | 76.00% |
| Switzerland | 12 | 12.00% |
| France | 12 | 12.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gary Phillips
- Personal Network
